Human Resources
Number and Qualification of Employees
On March 31, 2009, the MorphoSys Group employed 343 people (December 31, 2008: 334). On average, the MorphoSys Group employed 338 people for the first three months of 2009 (Q1 2008: 294).
Of the 343 employees, 112 people were employed in MorphoSys’s subsidiaries on March 31, 2009, and on average, 110 were employed (Q1 2008: 105 and 105 on average, respectively).
Of the 343 employees, 200 worked in research and development and 143 in sales, general and administration (December 31, 2008: 191 and 143, respectively).
On March 31, 2009, 92 of MorphoSys’s employees had a Ph.D. degree (December 31, 2008: 91).
Of the 343 employees, 212 worked for the Therapeutic Antibodies segment and 131 for the AbD segment (December 31, 2008: 201 and 133, respectively).
On March 31, 2009, MorphoSys had 2 apprenticeship positions (December 31, 2008: 2).
Senior Management Group – Appointments
In January 2009, MorphoSys announced the appointment of a new Head of its AbD Serotec business segment. Dieter Feger joined MorphoSys from Abbott Diagnostics, Illinois, a global leader in in vitro diagnostics. For the last four years, he held the position of Marketing Director - Global Marketing, most recently with responsibility for Infectious Diseases, Abbott Diagnostics' biggest reagent franchise. Prior to that, he spent 18 years with Abbott in Europe, in a variety of roles including sales, product management, operational management and marketing before moving to the US.
In February 2009, MorphoSys announced the appointment of a new Head of Preclinical Development & Project Management. Dr. Ulrich Moebius joined MorphoSys from Medigene AG. For the last nine years, he held the position of Head of Pre-clinical Development, where he was responsible for the company's preclinical activities in a range of development projects predominantly in cancer and contributed to the market approval of two medical therapies. Prior to his tenure at Medigene, he spent five years with the Deutsches Krebsforschungszentrum DKFZ, Heidelberg, the leading German biomedical research institute dedicated to cancer research and two years at the Dana-Farber Cancer Institute located in Boston, Massachusetts, USA. Dr. Moebius holds a PhD in immunology from Johannes Gutenberg University Mainz and qualified as a professor in Immunology at the University of Heidelberg.
Qualification, Training and Education
In order to further enable and strengthen AbD’s efforts in penetrating new and potentially lucrative diagnostics markets, Abd Serotec has initiated a training program with Learning Delta, an international consultancy company with specific expertise in the diagnostics industry.